Costa Rica vs Libya: Cause of death, by non-communicable diseases, ages 0-4, female
Costa Rica
42.3%
in 2021
Libya
41.6%
in 2021
Costa Rica rank
35th
Libya rank
37th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Costa Rica
- Libya
How they compare
Costa Rica currently reports 42.3% against 41.6% in Libya, a difference of 0.7%.
Across all 6 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 35th and Libya ranks 37th of 185 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.5% | 28.8% | 13.7% | Costa Rica |
| 2010s | 45.6% | 39.3% | 6.2% | Costa Rica |
| 2020s | 43.0% | 41.5% | 1.5% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Costa Rica or Libya?
- Costa Rica, at 42.3% against 41.6% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Costa Rica and Libya?
- 0.7%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Costa Rica and Libya rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Costa Rica ranks 35th and Libya ranks 37th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.